These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7684385)

  • 1. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
    Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
    J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
    Medinas RJ; Lambert DM; Tompkins WA
    J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
    Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
    J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro.
    Tanabe-Tochikura A; Tochikura TS; Blakeslee JR; Olsen RG; Mathes LE
    Antiviral Res; 1992 Aug; 19(2):161-72. PubMed ID: 1332602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Difluoromethoxy-4-quinolone derivatives as anti-feline immunodeficiency virus (FIV) agents: important structural features for inhibitory activity of FIV replication.
    Kashiwase H; Katsube T; Kimura T; Nishigaki T; Yamashita M
    J Vet Med Sci; 2000 May; 62(5):499-504. PubMed ID: 10852398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.
    Schwartz AM; McCrackin MA; Schinazi RF; Hill PB; Vahlenkamp TW; Tompkins MB; Hartmann K
    Am J Vet Res; 2014 Mar; 75(3):273-81. PubMed ID: 24564313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.
    Ma J; Kennedy-Stoskopf S; Jaynes JM; Thurmond LM; Tompkins WA
    J Virol; 2002 Oct; 76(19):9952-61. PubMed ID: 12208971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.
    Savarino A; Pistello M; D'Ostilio D; Zabogli E; Taglia F; Mancini F; Ferro S; Matteucci D; De Luca L; Barreca ML; Ciervo A; Chimirri A; Ciccozzi M; Bendinelli M
    Retrovirology; 2007 Oct; 4():79. PubMed ID: 17971219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of feline immunodeficiency virus infection by stromal cell-derived factor.
    Hosie MJ; Broere N; Hesselgesser J; Turner JD; Hoxie JA; Neil JC; Willett BJ
    J Virol; 1998 Mar; 72(3):2097-104. PubMed ID: 9499065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.
    Auwerx J; North TW; Preston BD; Klarmann GJ; De Clercq E; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):400-6. PubMed ID: 11809865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
    Tanabe T; Yamamoto JK
    J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of retrovirus-induced syncytium formation by photoproducts of a brominated 1,8-naphthalimide compound.
    Chanh TC; Lewis DE; Judy MM; Sogandares-Bernal F; Michalek GR; Utecht RE; Skiles H; Chang SC; Matthews JL
    Antiviral Res; 1994 Oct; 25(2):133-46. PubMed ID: 7847875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants.
    McCrackin Stevenson MA; McBroom DG
    Am J Vet Res; 2001 Apr; 62(4):588-94. PubMed ID: 11327469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of HIV-1 and inhibition of HIV-1-induced syncytia by 1,8-naphthalimide photoactive compound.
    Chanh TC; Lewis DE; Allan JS; Sogandares-Bernal F; Judy MM; Utecht RE; Matthews JL
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):891-6. PubMed ID: 8257636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro.
    Vonsover A; Loya S; Sredni B; Albeck M; Gotlieb-Stematsky T; Araf O; Hizi A
    AIDS Res Hum Retroviruses; 1992 May; 8(5):613-23. PubMed ID: 1381205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau.
    Pontzer CH; Yamamoto JK; Bazer FW; Ott TL; Johnson HM
    J Immunol; 1997 May; 158(9):4351-7. PubMed ID: 9126998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD
    Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic reactivation of latent feline immunodeficiency virus ex vivo in peripheral CD4+ T-lymphocytes.
    McDonnel SJ; Sparger EE; Luciw PA; Murphy BG
    Virus Res; 2012 Dec; 170(1-2):174-9. PubMed ID: 23073179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937).
    Uherová P; Schmidtmayerová H; Mayer V
    Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.